동결보존 백 및 냉동백 시장 : 보존 분석물 유형별(혈액, 생물제제, 조직), 주요 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카, 기타 지역)

Cryopreservation Bags and Freezing Bags Market Distribution by Type of Analyte Stored (Blood, Biologics and Tissues) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World)

US $ 4,799 ￦ 6,640,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,684,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,665,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 24,905,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 동결보존 백 및 냉동백 시장은 2035년까지의 예측 기간 동안 3.9%의 연평균 복합 성장률(CAGR)을 나타내 현재 2억 1,600만 달러에서 2035년까지 3억 1,600만 달러로 성장할 것으로 전망되고 있습니다.

이 시장 세분화는 시장 규모와 기회 분석을 다음 매개 변수로 구분합니다.

보존 분석물 유형별

• 혈액
• 생물제제
• 조직

주요 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 북아프리카
• 기타 지역

동결보존이란 구조적으로 온전한 살아있는 세포나 조직을 장기간 보존하기 위해 초저온을 이용하는 것입니다. 게다가, 동결이나 융해시에 막이 손상되면 삼투압 쇼크가 일어나고, 결국 세포사멸이 일어납니다.

생체재료의 동결보존은 제약분야에서 기존의 과제, 특히 살아있는 세포와 복잡한 조직의 생존율과 생존성과 관련된 과제를 해결할 수 있는 큰 가능성을 갖고 있습니다. 지키는 능력을 가지고 있기 때문에 중요한 실현 기술로서 인식되고 있습니다. 또한, 1980년대 이후, 줄기 세포, 특히 조혈 줄기 세포나 배성 줄기 세포의 장기 보존에 사용되는 동결보존 기술이 크게 진보해, 재생 의료나 바이오뱅크 등의 다양한 의료 응용에 있어 중요한 역할을 하고 있습니다.

동결보존 백 및 냉동백 시장 : 주요 인사이트

이 보고서는 동결보존 백 및 냉동백 시장의 현황을 파고 업계 내 잠재적인 성장 기회를 확인하고 있습니다.

• 현재, 30개 이상의 참가 기업이 70개 이상의 동결보존 백의 제조에 종사하고 있으며, 이러한 참가 기업의 대부분은 유럽에 본사를 두고 있습니다.
• 동결보존 백의 25% 가까이가 2유형 이상의 분석물을 보존 가능하고, 특히 40% 이상의 단층 동결보존 백은 출하와 보존의 목적으로 설계되고 있습니다.
• 세계 여러 기업이 ATMP와 제대혈 줄기세포를 포함한 다양한 샘플의 장기보존을 용이하게 하는 동결보존 백을 제공합니다.
• 비교적 집중한 시장이기 때문에 참가 기업은 자사 제품의 독자적인 판매 제안을 개발해, 치료 개발자의 전략적 파트너가 되는 것에 주력하고 있습니다

• 2035년에는 혈액백이 동결보존 백 및 냉동백의 총 수요의 70%를 차지할 것으로 전망됩니다. 이것은 혈액 질환의 유병률과 수혈율 증가에 기인하고 있습니다.
• 시장수익의 45% 이상은 아시아태평양을 거점으로 하는 진입기업별로 만들어질 것으로 예상되며, 이 영역에서는 인도와 중국이 주요 공헌자입니다.
• 생물제제를 보존하기 위한 동결보존 백 및 냉동백 수요는 세포요법과 유전자요법의 인기 급상승으로 인해 현저하게 상승하고 있으며, 2035년까지 270만개 이상에 달할 것으로 예측되고 있습니다.
• 생물제제 보존용의 동결보존 백과 냉동백의 예측되는 장래 기회는 다른 유형의 생물제제와 주요 지리적 지역에 잘 분배될 것으로 예측됩니다.
• 조직 보존용의 동결보존 백 및 냉동백 시장은 2035년까지 안정된 페이스로 성장할 것으로 예상됩니다.

동결보존 백 및 냉동백 시장 : 주요 부문

보존 분석물 유형별로는 시장은 혈액, 생물제제, 조직으로 구분됩니다.

주요 지역별로 볼 때 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동, 아프리카 및 기타 지역으로 구분됩니다. 현재 아시아태평양은 세계의 동결보존 백 및 냉동백 시장을 독점하여 최대 수익 점유율을 차지하고 있습니다.

본 보고서에서는 세계의 동결보존 백 및 냉동백 시장에 대해 조사했으며, 시장 개요와 함께 보존 분석물 유형별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서문

제1장 동결보존 백 및 냉동백 시장 개요

제2장 주요 요약

제3장 서론

• 장 개요
• 헬스케어에 있어서의 동결보존/냉동백의 역할
• 동결보존 백에 보존되는 분석물의 유형
• 동결보존 백의 장점
• 동결보존 백의 한계
• 향후 전망

제4장 동결보존 백 및 냉동백 : 시장 상황

• 장 개요
• 동결보존 백 및 냉동백 : 시장 상황

제5장 동결보존 백 및 냉동백 : 공급업체의 정세

• 장 개요
• 동결보존 백 및 냉동백 : 공급업체의 상황

제6장 제품 경쟁력 분석

• 장 개요
• 전제 및 주요 파라미터
• 조사 방법
• 동결보존 백 및 냉동백 : 제품 경쟁력 분석

제7장 기업 프로파일

• 장 개요
• American Durafilm
• Biomed Device
• CellBios
• Charter Medical
• Instant Systems
• Macopharma
• OriGen Biomedical
• Sartorius
• 기타 기업 프로파일
  • Advatis
  • Mitra
  • Pall
  • Saint Gobain Life Sciences
  • Shanghai LePure Biotech
  • Single Use Support
  • Takara Bio
  • Technoflex
  • Vogt Medical

제8장 시장 집중 분석

• 장 개요
• 전제 및 주요 파라미터
• 조사 방법
• 동결보존 백 및 냉동백 제공업체 : 시장 집중 분석

제9장 시장 평가와 기회 분석 : 혈액

• 장 개요
• 혈액 저장 시장 평가와 기회 분석(양별)
• 주요 전제와 조사 방법
• 세계의 동결보존 백 및 냉동백 수요, 혈액 보존용(-2035년, 100만개)
• 주요 지역별 분포
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동, 북아프리카 및 기타 지역
• 혈액 보관 시장 평가와 기회 분석(금액 기준)
• 주요 전제와 예측 조사 방법
• 세계의 동결보존 백 및 냉동백 시장, 혈액 보존용(-2035년, 100만 달러)
• 동결보존 백 및 냉동백, 혈액 보존용 : 주요 지역별 분포

제10장 시장 평가와 기회 분석 : 생물제제

제11장 시장 평가와 기회 분석 : 조직

제12장 결론

제13장 주요 인사이트

제14장 부록 I : 표 형식 데이터

제15장 부록 II : 기업 및 조직 목록

KTH

영문 목차

영문목차

CRYOPRESERVATION BAGS AND FREEZING BAGS MARKET: OVERVIEW

As per Roots Analysis, the global advanced wound care market is estimated to grow from USD 216 million in the current year to USD 316 million by 2035, at a CAGR of 3.9% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Analyte Stored

• Blood
• Biologics
• Tissues

Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and North Africa
• Rest of the World

CRYOPRESERVATION BAGS AND FREEZING BAGS MARKET: GROWTH AND TRENDS

Cryopreservation is the use of very low temperatures to preserve structurally intact living cells and tissues for a long period. Despite their immense potential for use in basic research and numerous other medical applications, simple cooling or freezing makes it impossible to store stem cells and other viable tissues for an extended period due to ice crystal formation. Moreover, damage to the membrane during freezing and thawing results in osmotic shock, which ultimately causes cell death. The aforementioned challenges prompted the researchers to explore the potential of cryobags that facilitate durable, transparent and flexible storage of analytes or biological materials at liquid nitrogen temperatures.

The cryopreservation of biomaterials has tremendous potential to address the existing challenges within the pharmaceutical sector, particularly those related to the survival rate and viability of living cells and complex tissues. Therefore, in the realm of regenerative medicines, cryopreservation is recognized as a key enabling technology given its ability to preserve the structural integrity and functionality of biological samples and therapies for large-scale clinical applications. Moreover, since the 1980s, there have been significant advancements in the cryopreservation techniques used for the potential long-term storage of stem cells, specifically hematopoietic stem cells and embryonic stem cells, which are crucial in various medical applications, such as regenerative medicine and biobanking.

CRYOPRESERVATION BAGS AND FREEZING BAGS MARKET: KEY INSIGHTS

The report delves into the current state of the cryopreservation bags and freezing bags market and identifies potential growth opportunities within the industry. Some key findings from the report include:

• At present, more than 30 players are engaged in the manufacturing of over 70 cryopreservation bags; the majority of these players are headquartered in Europe.
• Close to 25% of the cryobags are capable of storing more than one type of analyte; notably, over 40% of single-layered cryopreservation and freezing bags are designed for both shipping and storing purposes.
• Several players across the globe are offering cryobags to facilitate long-term preservation of a wide variety of samples, including ATMPs and cord blood stem cells.
• Being a relatively concentrated market, players are focused on developing unique selling propositions for their products and becoming strategic partners for therapy developers.

• In 2035, blood bags are likely to account for 70% of the total demand for cryopreservation bags and freezing bags; this can be attributed to the growing prevalence of blood disorders and transfusion rates.
• Over 45% of the market revenues are expected to be generated by players based in Asia-Pacific, with India and China being the major contributors in this domain.
• The demand for cryopreservation bags and freezing bags for storing biologics is rising significantly, owing to the surge in the popularity of cell and gene therapies; by 2035, it is anticipated to reach over 2.7 million units.
• The projected future opportunity for cryopreservation bags and freezing bags for biologics storage is expected to be well distributed across different types of biologics and key geographical regions.
• The cryopreservation bags and freezing bags market for tissue storage is likely to grow at a steady pace till 2035; the projected future opportunity is expected to be well distributed across key geographical regions.

CRYOPRESERVATION BAGS AND FREEZING BAGS MARKET: KEY SEGMENTS

Blood Segment Occupies the Largest Share of the Cryopreservation Bags and Freezing Bags Market

Based on the type of analyte stored, the market is segmented into blood, biologics and tissues. At present, cryopreservation bags and freezing bags for blood segment hold the maximum share of the global cryopreservation bags and freezing bags market. This is due to the growing prevalence of blood disorders and global transfusion rates. Additionally, the tissue freezing bags segment is likely to grow at a faster pace compared to the other segments.

Asia-Pacific Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa and Rest of the World. Currently, Asia-Pacific dominates the global cryopreservation bags and freezing bags market and accounts for the largest revenue share.

Example Players in the Cryopreservation Bags and Freezing Bags Market

• American Durafilm
• Biomed Device
• CellBios
• Charter Medical
• Instant Systems
• Macopharma
• OriGen Biomedical
• Sartorius

CRYOPRESERVATION BAGS AND FREEZING BAGS MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the cryopreservation bags and freezing bags market, focusing on key market segments, including [A] type of analyte stored and [B] key geographical regions.
• Cryopreservation Bags and Freezing Bags Market Landscape: A comprehensive evaluation of cryopreservation bags and freezing bags market, based on several relevant parameters, such as [A] type of analyte stored, [B] storage temperature, [C] application area and [D] type of packaging layer.
• Manufacturers Market Landscape: A comprehensive evaluation of companies providing cryopreservation bags and freezing bags, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of analyte stored, and [E] number of products offered.
• Product Competitiveness Analysis: A comprehensive competitive analysis of cryopreservation bags and freezing bags, examining factors, such as [A] supplier strength, [B] product competitiveness and [C] number of product variables.
• Company Profiles: In-depth profiles of key players engaged in the manufacturing of cryopreservation bags and freezing bags, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio, and [D] recent developments and [C] an informed future outlook. In addition, short profiles for some cryopreservation bag and freezing bag manufacturers have also been provided.
• Market Concentration Analysis: An insightful analysis of market concentration of companies in the industry, based on several parameters, such as [A] industry experience, [B] company size, [C] number of products offered, and [D] type of analyte stored.
• Demand Analysis: An insightful analysis of the demand for cryopreservation bags and freezing bags, based on key geographical regions.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

1.1. Cryopreservation Bags and Freezing Bags Market Overview

• 1.2. Key Market Insights
• 1.3. Scope of the Report
• 1.4. Market Segmentation
• 1.5. Research Methodology
• 1.6. Key Questions Answered
• 1.7. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Role of Cryopreservation / Freezing Bags in Healthcare
• 3.3. Types of Analytes Stored in Cryopreservation Bags
• 3.4. Benefits of Cryopreservation Bags
• 3.5. Limitations of Cryopreservation Bags
• 3.6. Future Perspectives

4. CRYOPRESERVATION BAGS AND FREEZING BAGS: MARKET LANDSCAPE

• 4.1. Chapter Overview
• 4.2. Cryopreservation Bags and Freezing Bags: Overall Market Landscape
  • 4.2.1. Analysis by Type of Analyte Stored
  • 4.2.2. Analysis by Storage Temperature
  • 4.2.3. Analysis by Type of Analyte Stored and Storage Temperature
  • 4.2.4. Analysis by Application Area
  • 4.2.5. Analysis by Type of Packaging Layer

5. CRYOPRESERVATION BAGS AND FREEZING BAGS: PROVIDER LANDSCAPE

• 5.1. Chapter Overview
• 5.2. Cryopreservation Bags and Freezing Bags: Provider Landscape
  • 5.2.1. Analysis by Year of Establishment
  • 5.2.2. Analysis by Company Size
  • 5.2.3. Analysis by Location of Headquarters
  • 5.2.4. Analysis by Type of Analyte Stored and Number of Products Offered

6. PRODUCT COMPETITIVENESS ANALYSIS

• 6.1. Chapter Overview
• 6.2. Assumptions and Key Parameters
• 6.3. Methodology
• 6.4. Cryopreservation Bags and Freezing Bags: Product Competitiveness Analysis
  • 6.4.1. Cryopreservation Bags and Freezing Bags Offered by Players based in North America
  • 6.4.2. Cryopreservation Bags and Freezing Bags Offered by Players based in Europe
  • 6.4.3. Cryopreservation Bags and Freezing Bags Offered by Players based in Asia-Pacific and Rest of the World

7. COMPANY PROFILES

• 7.1. Chapter Overview
• 7.2. American Durafilm
  • 7.2.1. Company Overview
  • 7.2.2. Product Portfolio
  • 7.2.3. Recent Developments and Future Outlook
• 7.3. Biomed Device
  • 7.3.1. Company Overview
  • 7.3.2. Product Portfolio
  • 7.3.3. Recent Developments and Future Outlook
• 7.4. CellBios
  • 7.4.1. Company Overview
  • 7.4.2. Product Portfolio
  • 7.4.3. Recent Developments and Future Outlook
• 7.5. Charter Medical
  • 7.5.1. Company Overview
  • 7.5.2. Product Portfolio
  • 7.5.3. Recent Developments and Future Outlook
• 7.6. Instant Systems
  • 7.6.1. Company Overview
  • 7.6.2. Product Portfolio
  • 7.6.3. Recent Developments and Future Outlook
• 7.7. Macopharma
  • 7.7.1. Company Overview
  • 7.7.2. Product Portfolio
  • 7.7.3. Recent Developments and Future Outlook
• 7.8. OriGen Biomedical
  • 7.8.1. Company Overview
  • 7.8.2. Product Portfolio
  • 7.8.3. Recent Developments and Future Outlook
• 7.9. Sartorius
  • 7.9.1. Company Overview
  • 7.9.2. Financial Information
  • 7.9.3. Product Portfolio
  • 7.9.4. Recent Developments and Future Outlook
• 7.10. Short Profiles
  • 7.10.1. Advatis
    • 7.10.1.1. Company Overview
  • 7.10.2. Mitra
    • 7.10.2.1. Company Overview
  • 7.10.3. Pall
    • 7.10.3.1. Company Overview
  • 7.10.4. Saint Gobain Life Sciences
    • 7.10.4.1. Company Overview
  • 7.10.5. Shanghai LePure Biotech
    • 7.10.5.1. Company Overview
  • 7.10.6. Single Use Support
    • 7.10.6.1. Company Overview
  • 7.10.7. Takara Bio
    • 7.10.7.1. Company Overview
  • 7.10.8. Technoflex
    • 7.10.8.1. Company Overview
  • 7.10.9. Vogt Medical
    • 7.10.9.1. Company Overview

8. MARKET CONCENTRATION ANALYSIS

• 8.1. Chapter Overview
• 8.2. Assumptions and Key Parameters
• 8.3. Methodology
• 8.4. Cryopreservation Bag and Freezing Bag Providers: Market Concentration Analysis

9. MARKET ASSESSMENT AND OPPORTUNITY ANALYSIS: BLOOD

• 9.1. Chapter Overview
• 9.2. Market Assessment and Opportunity Analysis for Blood Storage (by Volume)
• 9.3. Key Assumptions and Methodology
• 9.4. Global Demand for Cryopreservation Bags and Freezing Bags for Blood Storage, Till 2035 (Million Units)
• 9.5. Distribution by Key Geographical Regions
  • 9.5.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in North America, Till 2035 (Million Units)
    • 9.5.1.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in the US, Till 2035 (Million Units)
    • 9.5.1.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in Canada, Till 2035 (Million Units)
    • 9.5.1.3. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in Rest of North America, Till 2035 (Million Units)
  • 9.5.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in Europe, Till 2035 (Million Units)
    • 9.5.2.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in France, Till 2035 (Million Units)
    • 9.5.2.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in Germany, Till 2035 (Million Units)
    • 9.5.2.3. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in Italy, Till 2035 (Million Units)
    • 9.5.2.4. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in Spain, Till 2035 (Million Units)
    • 9.5.2.5. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in the UK, Till 2035 (Million Units)
    • 9.5.2.6. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in Rest of Europe, Till 2035 (Million Units)
  • 9.5.3. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in Asia-Pacific, Till 2035 (Million Units)
    • 9.5.3.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in China, Till 2035 (Million Units)
    • 9.5.3.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in India, Till 2035 (Million Units)
    • 9.5.3.3. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in Japan, Till 2035 (Million Units)
    • 9.5.3.4. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in South Korea, Till 2035 (Million Units)
    • 9.5.3.5. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in Rest of Asia-Pacific, Till 2035 (Million Units)
  • 9.5.4. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in Latin America, Till 2035 (Million Units)
  • 9.5.5. Annual Demand for Cryopreservation Bags and Freezing Bags for Blood Storage in Middle East and North Africa, and Rest of the World, Till 2035 (Million Units)
• 9.6. Market Assessment and Opportunity Analysis for Blood Storage (by Value)
• 9.7. Key Assumptions and Forecast Methodology
• 9.8. Global Cryopreservation Bags and Freezing Bags Market for Blood Storage, Till 2035 (USD Million)
• 9.9. Cryopreservation Bags and Freezing Bags for Blood Storage: Distribution by Key Geographical Regions
  • 9.9.1. Cryopreservation Bags and Freezing Bags Market for Blood Storage in North America, Till 2035 (USD Million)
    • 9.9.1.1. Cryopreservation Bags and Freezing Bags Market for Blood Storage in the US, Till 2035 (USD Million)
    • 9.9.1.2. Cryopreservation Bags and Freezing Bags Market for Blood Storage in Canada, Till 2035 (USD Million)
    • 9.9.1.3. Cryopreservation Bags and Freezing Bags Market for Blood Storage in Rest of North America, Till 2035 (USD Million)
  • 9.9.2. Cryopreservation Bags and Freezing Bags Market for Blood Storage in Europe, Till 2035 (USD Million)
    • 9.9.2.1. Cryopreservation Bags and Freezing Bags Market for Blood Storage in France, Till 2035 (USD Million)
    • 9.9.2.2. Cryopreservation Bags and Freezing Bags Market for Blood Storage in Germany, Till 2035 (USD Million)
    • 9.9.2.3. Cryopreservation Bags and Freezing Bags Market for Blood Storage in Italy, Till 2035 (USD Million)
    • 9.9.2.4. Cryopreservation Bags and Freezing Bags Market for Blood Storage in Spain, Till 2035 (USD Million)
    • 9.9.2.5. Cryopreservation Bags and Freezing Bags Market for Blood Storage in the UK, Till 2035 (USD Million)
    • 9.9.2.6. Cryopreservation Bags and Freezing Bags Market for Blood Storage in Rest of Europe, Till 2035 (USD Million)
  • 9.9.3. Cryopreservation Bags and Freezing Bags Market for Blood Storage in Asia-Pacific, Till 2035 (USD Million)
    • 9.9.3.1. Cryopreservation Bags and Freezing Bags Market for Blood Storage in China, Till 2035 (USD Million)
    • 9.9.3.2. Cryopreservation Bags and Freezing Bags Market for Blood Storage in India, Till 2035 (USD Million)
    • 9.9.3.3. Cryopreservation Bags and Freezing Bags Market for Blood Storage in Japan, Till 2035 (USD Million)
    • 9.9.3.4. Cryopreservation Bags and Freezing Bags Market for Blood Storage in South Korea, Till 2035 (USD Million)
    • 9.9.3.5. Cryopreservation Bags and Freezing Bags Market for Blood Storage in Rest of Asia-Pacific, Till 2035 (USD Million)
  • 9.9.4. Cryopreservation Bags and Freezing Bags Market for Blood Storage in Latin America, Till 2035 (USD Million)
  • 9.9.5. Cryopreservation Bags and Freezing Bags Market for Blood Storage in Middle East and North Africa, and Rest of the World, Till 2035 (USD Million)

10. MARKET ASSESSMENT AND OPPORTUNITY ANALYSIS: BIOLOGICS

• 10.1. Chapter Overview
• 10.2. Market Assessment and Opportunity Analysis for Cell Therapy Storage (by Volume)
• 10.3. Key Assumptions and Methodology
• 10.4. Global Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage, Till 2035 (Million Units)
• 10.5. Distribution by Key Geographical Regions
  • 10.5.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage in North America, Till 2035 (Million Units)
    • 10.5.1.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage in the US, Till 2035 (Million Units)
    • 10.5.1.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage in Canada, Till 2035 (Million Units)
  • 10.5.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage in Europe, Till 2035 (Million Units)
  • 10.5.3. Annual Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage in Asia-Pacific, Till 2035 (Million Units)
    • 10.5.3.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage in Australia, Till 2035 (Million Units)
    • 10.5.3.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage in China, Till 2035 (Million Units)
    • 10.5.3.3. Annual Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage in India, Till 2035 (Million Units)
    • 10.5.3.4. Annual Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage in Japan, Till 2035 (Million Units)
    • 10.5.3.5. Annual Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage in South Korea, Till 2035 (Million Units)
  • 10.5.4. Annual Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage in Latin America, Till 2035 (Million Units)
  • 10.5.5. Annual Demand for Cryopreservation Bags and Freezing Bags for Cell Therapy Storage in Middle East and North Africa, and Rest of the World, Till 2035 (Million Units)
• 10.6. Market Assessment and Opportunity Analysis for Gene Therapy Storage (by Volume)
• 10.7. Key Assumptions and Forecast Methodology
• 10.8. Global Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage, Till 2035 (Million Units)
• 10.9. Distribution by Key Geographical Regions
  • 10.9.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage in North America, Till 2035 (Million Units)
    • 10.9.1.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage in the US, Till 2035 (Million Units)
    • 10.9.1.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage in Canada, Till 2035 (Million Units)
  • 10.9.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage in Europe, Till 2035 (Million Units)
    • 10.9.2.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage in Ukraine, Till 2035 (Million Units)
  • 10.9.3. Annual Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage in Asia-Pacific, Till 2035 (Million Units)
    • 10.9.3.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage in Australia, Till 2035 (Million Units)
    • 10.9.3.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage in China, Till 2035 (Million Units)
    • 10.9.3.3. Annual Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage in Japan, Till 2035 (Million Units)
    • 10.9.3.4. Annual Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage in Philippines, Till 2035 (Million Units)
    • 10.9.3.5. Annual Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage in South Korea, Till 2035 (Million Units)
  • 10.9.4. Annual Demand for Cryopreservation Bags and Freezing Bags for Gene Therapy Storage in Latin America, Till 2035 (Million Units)
  • 10.9.5. Annual Demand for Cryopreservation Bags and Freezing Market for Gene Therapy Storage in Middle East and North Africa, and Rest of the World, Till 2035 (Million Units)
• 10.10. Market Assessment and Opportunity Analysis for Cell Therapy Storage (by Value)
• 10.11. Key Assumptions and Forecast Methodology
• 10.12. Global Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage, Till 2035 (USD Million)
• 10.13. Distribution by Key Geographical Regions
  • 10.13.1. Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage in North America, Till 2035 (USD Million)
    • 10.13.1.1. Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage in the US, Till 2035 (USD Million)
    • 10.13.1.2. Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage in Canada, Till 2035 (USD Million)
  • 10.13.2. Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage in Europe, Till 2035 (USD Million)
  • 10.13.3. Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage in Asia-Pacific, Till 2035 (USD Million)
    • 10.13.3.1. Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage in Australia, Till 2035 (USD Million)
    • 10.13.3.2. Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage in China, Till 2035 (USD Million)
    • 10.13.3.3. Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage in India, Till 2035 (USD Million)
    • 10.13.3.4. Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage in Japan, Till 2035 (USD Million)
    • 10.13.3.5. Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage in South Korea, Till 2035 (USD Million)
  • 10.13.4. Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage in Latin America, Till 2035 (USD Million)
  • 10.13.5. Cryopreservation Bags and Freezing Bags Market for Cell Therapy Storage in Middle East and North Africa, and Rest of the World, Till 2035

(USD Million)

• 10.14. Market Assessment and Opportunity Analysis for Gene Therapy Storage (by Value)
• 10.15. Key Assumptions and Forecast Methodology
• 10.16. Global Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage, Till 2035 (USD Million)
• 10.17. Distribution by Key Geographical Regions
  • 10.17.1. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in North America, 2023-37 (USD Million)
    • 10.17.1.1. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in the US, Till 2035 (USD Million)
    • 10.17.1.2. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in Canada, Till 2035 (USD Million)
  • 10.17.2. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in Europe, Till 2035 (USD Million)
    • 10.17.2.1. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in Ukraine, Till 2035 (USD Million)
  • 10.17.3. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in Asia-Pacific, Till 2035 (USD Million)
    • 10.17.3.1. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in Australia, Till 2035 (USD Million)
    • 10.17.3.2. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in China, Till 2035 (USD Million)
    • 10.17.3.3. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in Japan, Till 2035 (USD Million)
    • 10.17.3.4. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in Philippines, Till 2035 (USD Million)
    • 10.17.3.5. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in South Korea, Till 2035 (USD Million)
  • 10.17.4. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in Latin America, Till 2035 (USD Million)
  • 10.17.5. Cryopreservation Bags and Freezing Bags Market for Gene Therapy Storage in Middle East and North Africa, and Rest of the World, Till 2035 (USD Million)

11. MARKET ASSESSMENT AND OPPORTUNITY ANALYSIS: TISSUES

• 11.1. Chapter Overview
• 11.2. Market Assessment and Opportunity Analysis for Tissue Storage (by Volume)
• 11.3. Key Assumptions and Methodology
• 11.4. Global Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage, Till 2035 (Million Units)
• 11.5. Distribution by Key Geographical Regions
  • 11.5.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in North America, Till 2035 (Million Units)
    • 11.5.1.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in the US, Till 2035 (Million Units)
    • 11.5.1.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in Canada, Till 2035 (Million Units)
  • 11.5.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in Europe, Till 2035 (Million Units)
    • 11.5.2.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in France, Till 2035 (Million Units)
    • 11.5.2.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in Germany, Till 2035 (Million Units)
    • 11.5.2.3. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in Italy, Till 2035 (Million Units)
    • 11.5.2.4. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in Spain, Till 2035 (Million Units)
    • 11.5.2.5. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in the UK, Till 2035 (Million Units)
  • 11.5.3. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in Asia-Pacific, Till 2035 (Million Units)
    • 11.5.3.1. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in China, Till 2035 (Million Units)
    • 11.5.3.2. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in India, Till 2035 (Million Units)
    • 11.5.3.3. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in Japan, Till 2035 (Million Units)
    • 11.5.3.4. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in South Korea, Till 2035 (Million Units)
  • 11.5.4. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in Latin America, Till 2035 (Million Units)
  • 11.5.5. Annual Demand for Cryopreservation Bags and Freezing Bags for Tissue Storage in Middle East and North Africa, and Rest of the World, Till 2035 (Million Units)
• 11.6. Market Assessment and Opportunity Analysis for Tissue Storage (by Value)
• 11.7. Key Assumptions and Forecast Methodology
• 11.8. Global Cryopreservation Bags and Freezing Bags Market for Tissue Storage, Till 2035 (USD Million)
• 11.9. Distribution by Key Geographical Regions
  • 11.9.1. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in North America, Till 2035 (USD Million)
    • 11.9.1.1. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in the US, Till 2035 (USD Million)
    • 11.9.1.2. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in Canada, Till 2035 (USD Million)
  • 11.9.2. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in Europe, Till 2035 (USD Million)
    • 11.9.2.1. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in France, Till 2035 (USD Million)
    • 11.9.2.2. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in Germany, Till 2035 (USD Million)
    • 11.9.2.3. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in Italy, Till 2035 (USD Million)
    • 11.9.2.4. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in Spain, Till 2035 (USD Million)
    • 11.9.2.5. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in the UK, Till 2035 (USD Million)
  • 11.9.3. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in Asia-Pacific, Till 2035 (USD Million)
    • 11.9.3.1. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in China, Till 2035 (USD Million)
    • 11.9.3.2. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in India, Till 2035 (USD Million)
    • 11.9.3.3. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in Japan, Till 2035 (USD Million)
    • 11.9.3.4. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in South Korea, Till 2035 (USD Million)
  • 11.9.4. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in Latin America, Till 2035 (USD Million)
  • 11.9.5. Cryopreservation Bags and Freezing Bags Market for Tissue Storage in Middle East and North Africa, and Rest of the World, Till 2035 (USD Million)

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS

• 13.1. Chapter Overview
• 13.2. Charter Medical
  • 13.2.1. Company Snapshot
  • 13.2.2. Interview Transcript: Ian Burdick, Director, Product Management
• 13.3. Gore
  • 13.3.1. Company Snapshot
  • 13.3.2. Interview Transcript: Joe Cintavey, Product Specialist
• 13.4. Single Use Support
  • 13.4.1. Company Snapshot
  • 13.4.2. Interview Transcript: Pavan Patidar, Business Manager

14. APPENDIX I: TABULATED DATA

15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

관련자료